A patient with generalized myasthenia gravis facing an impending crisis triggered by early fast ‐acting treatment

ConclusionsSuch acute exacerbation after only 250 mg/day of IVMP for 2 days is rare. However, caution is needed when using IVMP for EFT of MG because the risk factors for exacerbation after IVMP use, and the best approach for treating the exacerbation, are not yet known.

Source: Clinical and Experimental Neuroimmunology - November 5, 2021 Category: Neurology Authors: Kana Tamaki, Yoichiro Nishida, Nobuo Sanjo, Takanori Yokota Tags: CASE REPORT Source Type: research